425 related articles for article (PubMed ID: 9543127)
1. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
Streeten DH; Anderson GH; Brennan S; Jones C
J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
[TBL] [Abstract][Full Text] [Related]
2. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
3. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
[TBL] [Abstract][Full Text] [Related]
4. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
[TBL] [Abstract][Full Text] [Related]
5. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Aron DC; Raff H; Findling JW
J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
8. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
[TBL] [Abstract][Full Text] [Related]
9. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
Krieger DT; Allen W
J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
[TBL] [Abstract][Full Text] [Related]
10. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
[TBL] [Abstract][Full Text] [Related]
11. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.
Findling JW; Raff H; Aron DC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614
[TBL] [Abstract][Full Text] [Related]
12. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
13. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
14. [Test of pituitary adrenal suppressibility with I.V. dexamethsaone in the diagnosis of Cushing's syndrome (author's transl)].
Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G
Pathol Biol (Paris); 1980 Feb; 28(2):85-9. PubMed ID: 7005835
[TBL] [Abstract][Full Text] [Related]
15. The 4-mg intravenous dexamethasone suppression test in the diagnosis of Cushing's syndrome.
Jung C; Alford FP; Topliss DJ; Burgess JR; Long F; Gome JJ; Stockigt JR; Inder WJ
Clin Endocrinol (Oxf); 2010 Jul; 73(1):78-84. PubMed ID: 20039897
[TBL] [Abstract][Full Text] [Related]
16. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
17. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
[TBL] [Abstract][Full Text] [Related]
18. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
[TBL] [Abstract][Full Text] [Related]
19. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
Watanobe H; Tamura T
J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
[TBL] [Abstract][Full Text] [Related]
20. Use of ketoconazole in the treatment of Cushing's syndrome.
Loli P; Berselli ME; Tagliaferri M
J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
